Zurzuvae to treat postpartum depression
Drug Name: Zurzuvae Indications: To treat postpartum depression. Active Ingredient: Zuranolone Company: Biogen Inc Approval Date: 8/4/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217369s000lbl.pdf